Article info

PDF
Original article
Declines in anogenital warts diagnoses since the change in 2012 to use the quadrivalent HPV vaccine in England: data to end 2017

Authors

  • Marta Checchi Blood Safety, Hepatitis, Sexually Transmitted Infections (STI) and HIV Service, National Infection Service, Public Health England, London, UK PubMed articlesGoogle scholar articles
  • David Mesher Blood Safety, Hepatitis, Sexually Transmitted Infections (STI) and HIV Service, National Infection Service, Public Health England, London, UK PubMed articlesGoogle scholar articles
  • Hamish Mohammed Blood Safety, Hepatitis, Sexually Transmitted Infections (STI) and HIV Service, National Infection Service, Public Health England, London, UK PubMed articlesGoogle scholar articles
  • Kate Soldan Blood Safety, Hepatitis, Sexually Transmitted Infections (STI) and HIV Service, National Infection Service, Public Health England, London, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Marta Checchi, Blood Safety, Hepatitis, Sexually Transmitted Infections (STI) and HIV Service, National Infection Service, Public Health England, London NW9 5EQ, UK; marta.checchi{at}phe.gov.uk
View Full Text

Citation

Checchi M, Mesher D, Mohammed H, et al
Declines in anogenital warts diagnoses since the change in 2012 to use the quadrivalent HPV vaccine in England: data to end 2017

Publication history

  • Received July 2, 2018
  • Revised November 1, 2018
  • Accepted November 29, 2018
  • First published February 5, 2019.
Online issue publication 
July 18, 2019

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.